Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Graham

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Science (New York, N.Y.)|September 28, 2013
Science education. Increasing persistence of college students in STEMMark J Graham, Jennifer Frederick, Angela Byars-Winston, et al.
Nucleic Acids Research|February 6, 2004
2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivoThazha P Prakash, Joseph F Johnston, Mark J Graham, et al.
Journal of Lipid Research|April 27, 2010
Recovery from liver disease in a Niemann-Pick type C mouse modelNaomi L Sayre, Victoria M Rimkunas, Mark J Graham, et al.
Metabolism: Clinical and Experimental|January 3, 2012
Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type dietGuoping Li, Antonio Hernandez-Ono, Rosanne M Crooke, et al.
Journal of Microbiology & Biology Education|November 1, 2018
The Need to Be Sure About CUREs: Discovery and Relevance as Critical Elements of CUREs for NonmajorsLisa A Corwin, Erin L Dolan, Mark J Graham, et al.
Journal of Lipid Research|March 3, 2011
Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolismGuoping Li, Antonio Hernandez-Ono, Rosanne M Crooke, et al.
Nucleic Acid Therapeutics|August 23, 2018
Characterization of the Activity and Distribution of a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide in Models of Acute and Chronic Kidney DiseaseAaron J Donner, Thomas A Bell, Sarah Greenlee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 7, 2016
Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone SignalingJing Liu, Antonio Hernandez-Ono, Mark J Graham, et al.
CBE Life Sciences Education|May 24, 2019
Supports: A Key Factor in Faculty Implementation of Evidence-Based TeachingMeghan E Bathgate, Oriana R Aragón, Andrew J Cavanagh, et al.
Journal of Cardiovascular Translational Research|July 17, 2013
Antisense technology: an emerging platform for cardiovascular disease therapeuticsRichard G Lee, Jeff Crosby, Brenda F Baker, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Science (New York, N.Y.)|September 28, 2013
Science education. Increasing persistence of college students in STEMMark J Graham, Jennifer Frederick, Angela Byars-Winston, et al.
Nucleic Acids Research|February 6, 2004
2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivoThazha P Prakash, Joseph F Johnston, Mark J Graham, et al.
Journal of Lipid Research|April 27, 2010
Recovery from liver disease in a Niemann-Pick type C mouse modelNaomi L Sayre, Victoria M Rimkunas, Mark J Graham, et al.
Metabolism: Clinical and Experimental|January 3, 2012
Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type dietGuoping Li, Antonio Hernandez-Ono, Rosanne M Crooke, et al.
Journal of Microbiology & Biology Education|November 1, 2018
The Need to Be Sure About CUREs: Discovery and Relevance as Critical Elements of CUREs for NonmajorsLisa A Corwin, Erin L Dolan, Mark J Graham, et al.
Journal of Lipid Research|March 3, 2011
Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolismGuoping Li, Antonio Hernandez-Ono, Rosanne M Crooke, et al.
Nucleic Acid Therapeutics|August 23, 2018
Characterization of the Activity and Distribution of a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide in Models of Acute and Chronic Kidney DiseaseAaron J Donner, Thomas A Bell, Sarah Greenlee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 7, 2016
Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone SignalingJing Liu, Antonio Hernandez-Ono, Mark J Graham, et al.
CBE Life Sciences Education|May 24, 2019
Supports: A Key Factor in Faculty Implementation of Evidence-Based TeachingMeghan E Bathgate, Oriana R Aragón, Andrew J Cavanagh, et al.
Journal of Cardiovascular Translational Research|July 17, 2013
Antisense technology: an emerging platform for cardiovascular disease therapeuticsRichard G Lee, Jeff Crosby, Brenda F Baker, et al.
Pageof 14